Skip to main content
. Author manuscript; available in PMC: 2013 Sep 5.
Published in final edited form as: Am Heart J. 2012 Mar 27;163(5):804–811. doi: 10.1016/j.ahj.2012.02.008

Figure 1.

Figure 1

Warfarin use in low (=1) versus high (≥2) CHADS2 scores by country. Across all countries, HF patients with higher risk of stroke received less anticoagulation with warfarin than lower-risk patients. The only exception was Indonesia, where higher-risk patients received more warfarin.